NORTHERA (DROXIDOPA) CAPSULES Trademark

Trademark Overview

On Monday, February 29, 2016, a trademark application was filed for NORTHERA (DROXIDOPA) CAPSULES with the United States Patent and Trademark Office. The USPTO has given the NORTHERA (DROXIDOPA) CAPSULES trademark a serial number of 86922769. The federal status of this trademark filing is SECTION 8 - ACCEPTED as of Wednesday, June 12, 2024. This trademark is owned by Lundbeck NA Ltd.. The NORTHERA (DROXIDOPA) CAPSULES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the prevention and treatment of Parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness and lightheadedness; all of the above-referenced goods containing in significant part DROXIDOPA
northera (droxidopa) capsules

General Information

Serial Number86922769
Word MarkNORTHERA (DROXIDOPA) CAPSULES
Filing DateMonday, February 29, 2016
Status701 - SECTION 8 - ACCEPTED
Status DateWednesday, June 12, 2024
Registration Number5291968
Registration DateTuesday, September 19, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 11, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "NORTHERA" in slate grey on one line and "(DROXIDOPA) CAPSULES" in blue on another line below it. In the upper right are five slightly overlapping stylized figures of a person in slate grey, blue, grey, and light grey in an arc. The white background represents transparent areas only and is not a feature of the mark.
Goods and ServicesPharmaceutical preparations for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations for the prevention and treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations for the prevention and treatment of Parkinson's disease and disorder; pharmaceutical preparations for the prevention and treatment of dizziness and lightheadedness; all of the above-referenced goods containing in significant part DROXIDOPA
Indication of Colors claimedThe color(s) slate grey, blue, grey, and light grey is/are claimed as a feature of the mark.
NOT AVAILABLE"(DROXIDOPA) CAPSULES"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 3, 2016
Primary Code005
First Use Anywhere DateThursday, December 11, 2014
First Use In Commerce DateThursday, December 11, 2014

Trademark Owner History

Party NameLundbeck NA Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameLundbeck NA Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameLundbeck NA Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, June 13, 2016ASSIGNED TO EXAMINER
Thursday, March 3, 2016NEW APPLICATION ENTERED
Thursday, March 3, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 4, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, June 23, 2016NON-FINAL ACTION WRITTEN
Thursday, June 23, 2016NON-FINAL ACTION E-MAILED
Thursday, June 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 11, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 11, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, August 25, 2016ASSIGNED TO LIE
Tuesday, August 30, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 30, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 21, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2016PUBLISHED FOR OPPOSITION
Tuesday, October 11, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 6, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 16, 2016TEAS STATEMENT OF USE RECEIVED
Friday, December 16, 2016USE AMENDMENT FILED
Thursday, January 12, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 12, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, January 13, 2017SU - NON-FINAL ACTION - WRITTEN
Friday, January 13, 2017NON-FINAL ACTION E-MAILED
Friday, January 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 13, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 13, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 11, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 12, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 19, 2017REGISTERED-PRINCIPAL REGISTER
Monday, September 19, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 18, 2023TEAS SECTION 8 RECEIVED
Thursday, December 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 14, 2023POST REGISTRATION ACTION MAILED - SEC. 8
Friday, March 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 11, 2024TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, June 12, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED
Wednesday, June 12, 2024NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Related Keywords

capsules droxidopa northera treatment prevention pharmaceutical preparations dizziness lightheadedness disease above disorder containing